Jordi Mata-Fink

Jordi Mata-Fink, co-founder of Gate Bioscience, discusses their work on commercializing a novel class of therapeutics called 'molecular gates' targeting extracellular proteins. He explores the power of platform-based problem-solving and team building in biotech startups, as well as the potential of small molecules to overcome therapeutic challenges. The episode also delves into the secretory translocon and the opportunities it presents for therapeutic intervention.